Modulation of the antigenic phenotype of human breast carcinoma cells by modifiers of protein kinase C activity and recombinant human interferons
- 1 September 1992
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 35 (5) , 315-324
- https://doi.org/10.1007/bf01741144
Abstract
In the present study we have analyzed the effect of a synthetic protein kinase C (PKC) activator 3-(N-acetylamino)-5-(N-decyl-N-methylamino)-benzyl alcohol (ADMB) and the natural PKC-activating tumor-promoting agents 12-O-tetradecanoylphorbol 13-acetate (TPA) and mezerein on the antigenic phenotype of T47D human breast carcinoma cells. All three agents increased the surface expression of the tumor-associated antigen BCA 225 and various cellular antigens, including HLA class II antigens, intercellular adhesion molecule 1 (ICAM-1) and c-erbB-2. Expression of the same antigens was also upregulated to various extents in T47D cells by recombinant fibroblast (IFNβ) and immune (IFNγ) interferon. Shedding of BCA 225 from T47D cells was induced by TPA, mezerein, IFNβ and IFNγ, whereas ADMB did not display this activity. The ability of ADMB, TPA and mezerein to modulate the antigenic phenotype of T47D cells appears to involve a PKC-mediated pathway, since the PKC inhibitor, H-7, eliminates antigenic modulation. In contrast, the ability of IFNβ and IFNγ to enhance the synthesis, expression and shedding of BCA 225, as well as to enhance HLA class II antigens, c-erbB-2 and ICAM-1 expression, was either unchanged or modestly reduced by simultaneous exposure to H-7. Analysis of steady-state mRNA levels for HLA class I antigens, HLA class II-DRβ antigen, ICAM-1 and c-erbB-2 indicated that the ability of H-7 to inhibit expression of these antigens in TPA-, mezerein- and ADMB-treated cells was not a consequence of a reduction in the steady-state levels of mRNAs for these antigens. The results of the present investigation indicate that the biochemical pathways mediating enhanced antigenic expression in T47D cells induced by TPA, mezerein and the synthetic PKC activator ADMB are different from those induced by recombinant interferons. Furthermore, up-regulation of antigenic expression in T47D cells can occur by a PKC-dependent or a PKC-independent pathway.Keywords
This publication has 59 references indexed in Scilit:
- Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferonsCancer Immunology, Immunotherapy, 1991
- Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferonInternational Journal of Cancer, 1990
- Differential modulation of keratinocyte intercellular adhesion molecule-i expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transductionBritish Journal of Dermatology, 1990
- Modulation of the Antigenic Phenotype of Human Melanoma Cells by Differentiation‐inducing and Growth‐suppressing AgentsPigment Cell Research, 1990
- Protein Kinase C Is Involved in the Early Signals of Interferon-α But Not of Interferon-γ in U937 CellsJournal of Interferon Research, 1990
- In vitro differentiation and antigenic changes in human melanoma cell linesCancer Immunology, Immunotherapy, 1989
- Early Events in Methyl Methanesulfonate Enhancement of Adenovirus Transformation of Cloned Rat Embryo Fibroblast CellsMolecular Carcinogenesis, 1989
- Modulation of protein kinase C activity during inhibition of tumor cell growth by IFN-β and -γBiochemical and Biophysical Research Communications, 1988
- Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferonsPharmacology & Therapeutics, 1985
- Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cellsNature, 1984